Seegene Advances Comprehensive HPV and STI PCR Screening
Seoul, South Korea, August 10, 2026 Seegene Inc. has announced a comprehensive approach to syndromic PCR screening for reproductive...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Seoul, South Korea, August 10, 2026 Seegene Inc. has announced a comprehensive approach to syndromic PCR screening for reproductive...
Burlington, North Carolina, USA, August 10, 2026 Labcorp has announced that the U.S. Food and Drug Administration (FDA) has...
Irving, Texas, USA, August 7, 2026 Caris Life Sciences has announced the publication of a new study demonstrating that...
Salt Lake City, Utah, USA, August 7, 2026 Co-Diagnostics, Inc. has reached a major regulatory milestone by submitting a...
Seoul, South Korea, August 5, 2026 Seegene Inc., a global leader in molecular diagnostics, has unveiled a comprehensive PCR-based...
Ipswich, Massachusetts – August 4, 2026 New England Biolabs (NEB®) has expanded its molecular biology portfolio with the launch...
Boston, Massachusetts & Rolle, Switzerland, August 4, 2026 SOPHiA GENETICS has entered into a global multi-year collaboration with AstraZeneca...
PLEASANTON, Calif., July 29, 2026 10x Genomics has entered a multi-year research collaboration with Lausanne University Hospital (CHUV) to...
TOKYO, July 22, 2026 Kirin Holdings Company, Limited and Blackmores Limited have announced the launch of two new Cognizin®...
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has announced a comprehensive Syndromic...
